Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi Post author: Post published:June 19, 2024 Post category:uncategorized A genetic treatment targeting the causal NRAS c.181C>A mutation in congenital melanocytic naevus. You Might Also Like Study advocates for liberal blood transfusions in TBI intensive care June 13, 2024 Study looks at ways to more accurately predict when migraine attack will occur January 24, 2024 Study suggests beta-blockers may elevate depression symptoms in post-MI patients November 13, 2024